Deaths of 3 children at GPHC
The doctors who treated the three juvenile leukaemia patients who later died at the Georgetown Public Hospital Corporation (GPHC) administered the drugs incorrectly. Instead of intrathecal administration of the drug vincristine, they administered it intravenously. It was this that led to the adverse reactions of those three children and ultimately their deaths.
This is according to Deputy Chief Medical Officer (CMO), Dr Karen Gordon-Campbell, who on Friday at the GPHC’s press briefing, stated that investigations revealed that protocols the medical practitioners should have followed would have stipulated which drug has to be administered “when and where.”

“It wasn’t a question of dosage but administration in terms of where it was administered. That was done incorrectly. The dosages would have been fine but in terms of where they administered what,” the Deputy CMO explained.
She stated that the three medical personnel involved in the matters were aware that they had broken protocol but not at the initial stage of administering the medicinal drugs to those patients.

“The reasons that were given encompassed the fact that they were stretched and maybe not fully attentive at the time. That pretty much is the long and short of the reasons given but I don’t think that initially, they realised. But eventually, when they recognised that the patients were deteriorating when they checked they realised their mistake.”
Deficiencies
Meanwhile, Chairperson of the Board of Directors at the GPHC, Kesaundra Alves told the media that an internal investigation by the hospital’s administration into the circumstances surrounding the treatment of three leukaemia patients and their subsequent adverse reactions has revealed that human deficiencies and systemic challenges contributed to the demise of those three children.









